| Title |
Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
|
|---|---|
| Published in |
Diabetes Therapy, November 2013
|
| DOI | 10.1007/s13300-013-0048-5 |
| Pubmed ID | |
| Authors |
Yoshiki Kusunoki, Tomoyuki Katsuno, Kana Miyakoshi, Takashi Ikawa, Rie Nakae, Fumihiro Ochi, Masaru Tokuda, Takafumi Akagami, Kazuki Murai, Masayuki Miuchi, Tomoya Hamaguchi, Jun-ichiro Miyagawa, Mitsuyoshi Namba |
| Abstract |
Insulin degludec is a new, ultra-long-acting basal insulin. The aim of this study was to analyze the changes of basal insulin dose and blood glucose profile in basal-bolus therapy of type 1 diabetes mellitus (T1DM) at the switching of basal insulin from insulin glargine or detemir to insulin degludec. |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 33 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 5 | 15% |
| Student > Ph. D. Student | 4 | 12% |
| Student > Postgraduate | 4 | 12% |
| Student > Bachelor | 4 | 12% |
| Lecturer | 3 | 9% |
| Other | 11 | 33% |
| Unknown | 2 | 6% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 48% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 12% |
| Agricultural and Biological Sciences | 1 | 3% |
| Computer Science | 1 | 3% |
| Energy | 1 | 3% |
| Other | 5 | 15% |
| Unknown | 5 | 15% |